BNOV vs UPAR
Innovator US Equity Buffer ETF - November vs UPAR Ultra Risk Parity ETF
Which is better, BNOV or UPAR?
BNOV has been ahead.
UPAR has a lower expense ratio. BNOV led over 1Y, 3Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BNOV | UPAR |
|---|---|---|
| Expense Ratio | 0.79% | 0.68%Best |
| AUM | $201M | $54M |
| Dividend Yield | 0.00% | 3.47% |
| Holdings | 18 | 141 |
| YTD Return | +11.13%Best | -0.01% |
| 1Y Return | +13.58%Best | +1.17% |
| 3Y Return (annualized) | +13.95%Best | +12.12% |
| 5Y Return (annualized) | +8.95% | - |
| Volatility (annualized) | 11.2%Best | 19.6% |
| Max Drawdown | -16.3%Best | -39.0% |
| $10,000 over 4.8 years | $14,971Best | $8,987 |
| Fund Family | Innovator ETFs Trust | Rpar ETF |
| Category | Alternative | Alternative |
| Style | Multi Alternative | Multi Alternative |
| Inception | Nov 1, 2019 | Jan 3, 2022 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 4.8 years row, are measured over the window both funds cover: Jan 4, 2022 to Oct 14, 2026 (4.8 years).
BNOV vs UPAR growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 4.8 years both funds cover.
BNOV vs UPAR Performance
Innovator US Equity Buffer ETF - November (BNOV) is an ETF from Innovator ETFs Trust and UPAR Ultra Risk Parity ETF (UPAR) is an ETF from Rpar ETF. Over the past year BNOV returned +13.58% while UPAR returned +1.17%. Year to date, BNOV is up 11.13% versus a loss of 0.01% for UPAR.
Over three years, BNOV compounded at +13.95% per year against +12.12% for UPAR.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
UPAR has been the more volatile fund, with annualized monthly volatility of 19.6% compared with 11.2% for BNOV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -16.3% for BNOV and -39.0% for UPAR. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.75. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
BNOV charges 0.79% per year while UPAR charges 0.68%. On a $10,000 position that is $79 vs $68 annually, a gap of $11 per year that compounds over a long holding period. On income, BNOV currently yields 0.00% against 3.47% for UPAR.
You are not choosing between two funds in isolation.
Whichever of BNOV and UPAR you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BNOV or UPAR?
BNOV has an expense ratio of 0.79% while UPAR charges 0.68%. UPAR is the cheaper option, by $11 a year on a $10,000 investment.
Which performed better, BNOV or UPAR?
Over the past year BNOV returned +13.58% vs +1.17% for UPAR, so BNOV leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BNOV or UPAR?
UPAR has been the more volatile fund at 19.6% annualized versus 11.2% for BNOV. Worst drawdown: BNOV -16.3% vs UPAR -39.0%.
Should I hold both BNOV and UPAR?
BNOV and UPAR have a monthly-return correlation of 0.75, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, BNOV or UPAR?
BNOV yields 0.00% while UPAR yields 3.47%, so UPAR currently pays the higher dividend yield.
Is UPAR better than BNOV?
UPAR has a lower expense ratio. BNOV led over 1Y, 3Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.